Strides Arcolab Enters into Agreement with Gilead Sciences

Strides Arcolab Enters into Agreement with Gilead Sciences

On Tuesday, an announcement was made that Strides Arcolab Limited has signed a licensing agreement with Gilead Sciences for marketing HIV drugs.

Under the agreement, Gilead has extended non-exclusive rights to the Indian firm to manufacture and distribute Tenofovir Alafenamide (TAF). TAF utilized for treatment of AIDS. With the help of this license, Strides can distribute this drug to about 112 countries which will together account for over 30 million people living with HIV.

As part of the licensing agreement, Strides is going to get a technology transfer from Gilead. Strides will be allowed to make low-cost versions of TAF for developing countries. On Tuesday, Strides shares increased by 1.32% at Rs 938.7, intra-day on the Bombay Stock Exchange.

Last week Gilead faced setback because Indian Patent Controller rejected Gilead’s key patent applications for drug sofosbuvir, utilized to treat hepatitis C (HCV). Back in November 2013, the oral drug received approval in the United States. In India, Patent applications on sofosbuvir were challenged by the Initiative for Medicines, Access & Knowledge and the Delhi Network of Positive People in November 2013 and March 2014.

TAF is a novel nucleotide reverse transcriptase inhibitor that has shown high antiviral effectiveness at a dose 10 times lower than Gilead’s Viread. In the US, TAF and TAF-based regimens are investigational products and yet it has not been determined safe or effective in humans.

Strides Arcolab is a Bangalore-based pharmaceutical company and it concentrates on development and manufacture of IP-led niche generics and bio-pharmaceuticals. Strides has eight manufacturing facilities with presence in over 75 countries in developed and emerging markets.


User login



You May Have Missed...

Charitable organization calls Government protection for B.C.'s glass sponge reef
Sat, 06/27/2015 - 14:10

The Canadian Parks and Wilderness Society that works to protect Canada's natural areas is concerned that the protection efforts by the Department...


Nigeria Update

Fresh Polio Cases lead to WHO Travel Restrictions on Pakistan and Syria
Tue, 05/06/2014 - 00:45

World Health Organization has slapped international travel restrictions on Pakistan, Cameroon...


Economy Watch

Yellen Indicates Interest Rate Increase if the Economy Continues to Perform
Sat, 05/23/2015 - 08:58

This month, the selloff in Treasuries had a connection to the bond commotion in Europe. Janet...


Health Tonight

Scientists Debunk belief that Global Warming reduces Winter-related Deaths
Wed, 06/24/2015 - 12:10

A new study from the researchers from the Columbia University‘s Mailman School of Public Health...


Science Tonight

NASA Working On Transforming Mars to Make It Habitable For Humans
Fri, 06/26/2015 - 12:46

An ongoing program at the Pentagon’s advanced research division is looking forward to create...


UK News

University student creates cookery kit to cook insects
Fri, 05/15/2015 - 01:51

AnEdinburgh student has developed a cookery kit in order to encourage people to eat insects,...


Pharmaceuticals

Astrazeneca’s Experimental Drug to Treat COPD Fails to Reduce Acute Exacerbation
Mon, 09/08/2014 - 13:17

On Monday, AstraZeneca PLC announced that Phase IIa study of benralizumab, an experimental drug...


US News

New iPhone App to Carry out Ever Largest Nationwide Health Study of LGBT
Fri, 06/26/2015 - 13:04

A team of researchers is to carry out the largest ever nationwide health study of LGBT...


Technology Tonight

Apple trying to ensure greater performance standards from its older devices
Sat, 05/23/2015 - 08:31

In what apparently is somewhat of a 'back to basics' move by US tech giant Apple, the company...